Landi D. Continuation of natalizumab versus interruption is associated with lower risk of relapses during pregnancy and postpartum in women with MS. Abstract 338. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Placebo even effectief als amitriptyline of topiramaat bij kind met migraine
jan 2017 | Hoofdpijn